GO:0090326 positive regulation of locomotion involved in locomotory behavior

GO:0090326, positive regulation of locomotion involved in locomotory behavior, is a Gene Ontology biological_process term that captures any process which increases the frequency, rate, or extent of self-propelled movement of a cell or organism from one location to another in a behavioral context. Unlike generic locomotion terms, it is explicitly tied to behavior: the movement must be part of a behavioral program, such as an escape response, foraging, or stress-induced swimming. This distinction matters because the same molecular pathway can drive non-behavioral cell motility and behaviorally gated locomotion through different upstream regulators. Researchers study GO:0090326 to understand how neural and endocrine signals convert sensory input into increased movement. In zebrafish larvae, acute thermal stress engages brain monoamines and corticotropin-releasing hormone receptor 1 (CRHR1) to modulate behavioral responses, including locomotion. In cancer biology, hybrid cells derived from breast epithelial/breast cancer cell fusion events show differential RAF-AKT crosstalk that can alter migratory behavior, illustrating how the same term can apply to pathological cell locomotion. Because the term is defined by a positive regulatory outcome, experimental work must show that a perturbation increases movement rather than merely correlating with it. This makes loss-of-function and gain-of-function CRISPR models, combined with quantitative behavioral or migration assays, the gold standard for assigning genes to GO:0090326.

In plain terms, GO:0090326 is the set of biological processes that make an organism or cell move more, faster, or farther when that movement is part of a behavior. The QuickGO definition states: any process that increases the frequency, rate, or extent of the self-propelled movement of a cell or organism from one location to another in a behavioral context; the aspect of locomotory behavior having to do with movement. It is a positive regulatory term, so it excludes processes that decrease locomotion and excludes movement that is not embedded in a behavioral context.

GO:0090326 matters because behavioral locomotion is a final common output of nervous system function, and its positive regulation determines how organisms escape threats, find resources, and respond to stress. Disruptions in this process are relevant to neuropsychiatric and stress-related phenotypes, while in cancer the same term describes how hybrid or transformed cells acquire increased migratory capacity. Assigning genes to this term requires causal evidence that a perturbation increases behaviorally contextualized movement, which is exactly what CRISPR-based models can provide.

The following genes and proteins have been experimentally linked to positive regulation of locomotion in behavioral or migration contexts in the verified literature.

Positive regulation of locomotion involved in locomotory behavior is itself regulated by neuromodulatory and endocrine inputs. In zebrafish larvae, brain monoamine changes modulate the CRHR1-mediated behavioral response to acute thermal stress, indicating that monoaminergic tone sets the gain on stress-induced locomotion. In hybrid breast epithelial/cancer cells, differential RAF-AKT crosstalk regulates migratory behavior, showing that intracellular signaling balance can positively regulate cell locomotion. These examples indicate that GO:0090326 is controlled at multiple levels: neural/endocrine modulation of behavioral drive and intracellular kinase crosstalk in cell migration models.

Because CRHR1 and monoamine signaling modulate behavioral responses to acute thermal stress in zebrafish larvae, dysregulation of these pathways may contribute to altered stress-related locomotor behavior. This provides a mechanistic entry point for studying neurobehavioral conditions in which movement responses to stressors are abnormal.

Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show differential RAF-AKT crosstalk associated with altered migratory behavior. This links positive regulation of cell locomotion to cancer biology, where increased migration is a step toward dissemination.

Breast epithelial/breast cancer cell fusion generates hybrid cells with distinct signaling and migratory properties, suggesting that fusion events can positively regulate locomotion in a pathological context. This supports the idea that GO:0090326 can be co-opted in disease.

Quantitative behavioral tracking under acute thermal stress can measure frequency, rate, and extent of locomotion, allowing direct testing of positive regulation in a behavioral context. Combining tracking with genetic perturbation of crhr1 or monoamine pathways links genes to GO:0090326.

Live imaging of hybrid breast epithelial/cancer cells can quantify migratory behavior and test whether RAF-AKT crosstalk positively regulates locomotion at the cellular level. This approach is complementary to organismal behavioral assays.

RNA-seq and proteomics can identify signaling changes associated with increased locomotion, such as monoamine-related gene expression or RAF-AKT pathway components. These readouts help nominate candidate regulators for functional testing.

Pharmacological modulation of monoamines or CRHR1 signaling, combined with CRISPR genetic models, can establish causality for positive regulation of behavioral locomotion. In cell models, kinase inhibitors or genetic knockouts can test RAF-AKT contributions to migration.

Researchers studying positive regulation of locomotion involved in locomotory behavior-related genes often need to determine whether a candidate gene is causally involved in increasing movement, rather than merely correlated with it. CRISPR-based models provide the necessary perturbation tools to move from association to causation in zebrafish behavioral assays and mammalian cell migration systems.

GO:0090326 provides a precise vocabulary for the positive regulation of behaviorally contextualized locomotion, bridging neural/endocrine modulation and cell migration signaling. Verified studies in zebrafish larvae and breast hybrid cells show that CRHR1, monoamines, and RAF-AKT crosstalk are central to this process. CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential for moving from correlation to causation in this field.